Organ-on-chip is a revolutionizing technology that utilizes miniaturized components to create a three-dimensional cultures of human cells grown in a microfluidic system. In recent years, pharmaceutical companies have been increasingly interested in organ on chip technology as a way to improve drug discovery and development.
For adoption in the industry, the technology must be able to rapidly generate large volumes of data and needs, therefore, to be compatible with lab automation procedures.
At Mimetas we develop and commercialize the OrganoPlate, a microfluidic organ-on-chip platform designed to meet the throughput requirements of the industry. The microfluidic culture units are embedded within a plate with common microtiter plate dimensions, thus making it compatible with standard lab automation procedures and equipment.
With this setup, we successfully conducted drug screenings on advanced three-dimensional tissue models paving the way for industry adoption of advanced in vitro systems in the drug development pipeline.
Speaker: Flavio Bonanini, Mimetas